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ABSTRACT
Introduction. This is the 2017 Annual Report of the University of 
Kansas Health System Poison Control Center (PCC). The PCC is 
one of 55 certified poison control centers in the United States and 
serves the state of Kansas 24-hours a day, 365 days a year. The PCC 
receives calls from the public, law enforcement, health care profes-
sionals, and public health agencies, which are answered by trained 
and certified specialists in poison information with the immediate 
availability of medical toxicology back up. All calls to the PCC are 
recorded electronically in the Toxicall® data management system 
and uploaded in near real-time to the National Poison Data System 
(NPDS), which is the data repository for all poison control centers 
in the United States.
Methods.xAll encounters reported to the PCC from January 1, 2017 
to December 31, 2017 were analyzed. Data recorded for each expo-
sure included caller location, age, weight, gender, substance exposed 
to, nature of exposure, route of exposure, interventions, medical 
outcome, disposition and location of care. Encounters were classified 
further as human exposure, animal exposure, confirmed non-expo-
sure, or information call (no exposure reported).
Results. The PCC logged 21,431 total encounters in 2017, includ-
ing 20,278 human exposure cases. Cases came from every county 
in Kansas. Most of the human exposure cases (51.4%, n = 10,430) 
were female. Approximately 66% (n = 13,418) of human exposures 
involved a child (defined as age less than 20 years). Most encounters 
occurred at a residence (94.0%, n = 19,018) and most calls (69.5%, n 
= 14,090) originated from a residence. Almost all human exposures 
(n = 19,823) were acute cases (exposures occurring over eight hours 
or less). Ingestion was the most common route of exposure docu-
mented (80.5%, n = 17,466). The most common reported substance 
in pediatric encounters was cosmetics/personal care products (n 
= 1,255), followed by household cleaning products (n = 1,251). For 
adult encounters, analgesics (n = 1,160) and sedatives/hypnotics/
antipsychotics (n = 1,127) were the most frequently involved sub-
stances. Unintentional exposures were the most common reason 
for exposures (78.6%, n = 15,947). Most encounters (69.4%, n = 
14,073) were managed in a non-health care facility (i.e., a residence). 
Among human exposures, 14,940 involved exposures to pharmaceu-
tical agents, while 9,896 involved exposure to non-pharmaceuticals. 
Medical outcomes were 28% (n = 5,741) no effect, 18% (n = 3,693) 
minor effect, 9% (n = 1,739) moderate effect, and 2% (n = 431) major 
effect. There were 16 deaths in 2017 reported to the PCC. Number 
of exposures, calls from health care facilities, cases with moderate or 
major medical outcomes, and deaths increased in 2017 compared to 
2016, despite a decrease in total exposures.
Conclusions. The results of the 2017 University of Kansas Health 
System Poison Control annual report demonstrated that the center 
continues to receive calls from the entire state of Kansas, totaling over 
20,000 human exposures per year. While pediatric exposures remain 
the most common, a trend of increasing number of calls remains from 
health care facilities and for cases with serious outcomes. The 2017 
PCC data reflected current national trends. This report demonstrat-
ed the continued importance of the PCC to both the public and health 
care providers in the state of Kansas.
Kans J Med 2019;12(3):70-79.
INTRODUCTION
This is the 2017 Annual Report of University of Kansas Health 
System Poison Control Center (PCC). The PCC is a 24-hour 365 
day/year health care information resource serving the state of Kansas. 
It was founded in 1982 and is certified with the American Association 
of Poison Control Centers (AAPCC). There are 55 certified poison 
control centers in the United States. The PCC is staffed by nine cer-
tified specialists in poison information who are either critical care 
trained nurses or doctors of pharmacy. There is 24-hour back-up pro-
vided by four fellowship trained, board certified medical toxicologists. 
The PCC receives calls from the public, law enforcement, health 
care professionals, and public health agencies. Encounters may 
involve an exposed animal or human (Exposure Call) or a request for 
information with no known exposure (Information Call). The PCC 
follows all cases to make management recommendations, monitor 
case progress, and document medical outcome. This information is 
recorded electronically in the Toxicall® data management system 
and uploaded in near real-time to the National Poison Data System 
(NPDS). NPDS is the data warehouse for all the nation’s poison 
control centers.1 The average time to upload data for all PCCs is 
9.50 [7.33, 14.6] (median [25%, 75%]) minutes, creating a real-time 
national exposure database and surveillance system. The PCC has 
the ability to share NPDS real time surveillance with state and local 
health departments and other regulatory agencies. An analysis and 
summary of all encounters reported to the PCC from January 1, 2017 
to December 31, 2017 follows.
METHODS
All PCC encounters recorded electronically in the Toxicall® data 
management system from January 1, 2017 to December 31, 2017  were 
analyzed. Cases were first classified as either an exposure or suspect-
ed exposure (Human Exposure, Animal Exposure, Non-Exposure 
Confirmed Cases) or a request for information with no reported 
exposure (Information Call). Extracted data included caller location, 
age, weight, gender, exposure substance, number of follow-up calls, 
nature of exposure (i.e., unintentional, recreational, or intentional), 
exposure scenario, route of exposure (oral, dermal, parenteral), 
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interventions, medical outcome (no effect, minor, moderate, severe 
or death), disposition (admitted to noncritical care unit, admitted 
to critical care unit, admitted to psychiatry unit, lost to follow-up or 
treated and released), and location of care (non-health care facility 
or health care facility). For this analysis, a pediatric case was defined 
as any patient 19 years of age or less. This is consistent with NPDS 
methodology. For medical outcome, the following definitions were 
used: minor (minimally bothersome symptoms), moderate (more 
pronounced symptoms, usually requiring treatment), and major (life 
threatening signs and symptoms).
Data were analyzed using Microsoft Excel (Microsoft Corp, 
Redmond, WA).
RESULTS
The PCC logged 21,431 total calls in 2017, including 20,278 human 
exposure cases, 77 non-exposure confirmed cases, 119 animal expo-
sure cases, and 957 information calls. This was a decrease of 534 
calls (2.4%) compared to 2016. For information calls, drug informa-
tion (n = 311) was most common reason for calling. Table 1 further 
describes the encounter types. The PCC made 31,715 follow-up calls 
in 2017. Follow-up calls were done in 58.8% of human exposure 
cases. One follow-up call was made in 26.9% of human exposure 
cases; multiple follow-up calls (range 2 - 45) were made in 32.0% of 
cases. In human exposure calls for which follow-up calls were made, 
an average of 2.66 follow-up calls per case were performed. 
The PCC received calls from all 105 counties in Kansas. The 
county with the largest number of calls was Sedgwick County with 
3,260. In addition, calls were received from 48 states, the District 
of Columbia, Puerto Rico, and the US Virgin Islands; five calls were 
from foreign countries.
The majority of human exposure cases (51.4%, n = 10,430) 
were female. A male predominance was found among encounters 
involving children younger than 13 years of age, but this gender 
distribution was reversed in teenagers and adults, with females 
comprising most of the reported exposures. Approximately 66% 
(n = 13,418) of human exposures involved a child (defined as age 19 
years or less). Table 2 illustrates distribution of human exposures 
by age and gender. Patients one year of age were the most common 
age group involved in encounters reported to the PCC. For adults, 
the age group of 20 - 29 years old was most commonly encountered. 
Seventy-seven (77) exposures occurred in pregnant women (0.4% 
of all human exposures). Of these exposures, 29.9% occurred in the 
first trimester, 37.7% occurred in the second trimester, and 27.3% 
occurred in the third trimester. Most of these exposures (71.4%) 
were unintentional exposures and 19.5% were intentional exposures. 
There were no reported deaths to PCC in pregnant women in 2017.
Table 1. Encounter type. 
Number %
Exposure
Human exposure 20,278 94.32
Animal exposure 119 0.51
Subtotal 20,397 94.83
Non-Exposure Confirmed Cases
Human non-exposure 77 0.39
Subtotal 77 0.39
Information Call
Drug information 311 1.40
Drug identification 117 0.86
Environmental information 94 0.56
Medical information 14 0.14
Occupational information 5 0.00
Poison information 112 0.50
Prevention/safety/education 19 0.14
Teratogenicity information 4 0.00
Other information 46 0.22
Substance abuse 11 0.03
Administrative 6 0.07
Caller referred 218 0.86
Subtotal 957 4.78
Total 21,431 100.00
For human exposures, 69.5% (n = 14,090) of calls originated 
from a residence (own or other), while 93.8% (n = 19,018) of these 
exposures actually occurred at a residence (own or other). Calls 
from a health care facility accounted for 24.1% (n = 4,892) of human 
exposure encounters. Table 3 further details the origin of human 
exposure calls and where the exposure took place.
Human exposures were predominantly (87.3 %, n = 17,694) acute 
cases (i.e., exposures occurring over eight hours or less). Chronic 
exposures (exposures occurring more than eight hours) accounted 
for 1.8% (365) of all human exposures reported. Acute or chronic 
exposures (single exposure that was preceded by a chronic exposure 
of more than eight hours) totaled 2,129 (10.5%). Ingestion was the 
most common route of exposure documented (80.5%, n = 17,466; 
Table 4) in all cases.
The most common reported substance in those less than five years 
of age was cosmetics/personal care products (n = 1,255) followed 
closely by household cleaning products (n = 1,251). For adult (> 19 
years of age) encounters, analgesics (n = 1,160) and sedatives/hyp-
notics/antipsychotics (n = 1,127) were the most frequently involved 
substances. Among all encounters, analgesics (n = 2,833, 11.3%) 
were the most frequently encountered substance category. Table 5 
lists most frequently encountered substance categories for pediatric 
encounters and Table 6 lists those for adult encounters. A summary 
log for all exposures categorized by category and sub-category of sub-
stance is presented in an online supplemental appendix ( journals.
ku.edu/kjm).
KANSAS JOURNAL of  M E D I C I N E
                 2017 POISON CONTROL CENTER REPORT  
                    continued.
Table 2. Distribution of human exposures by age and gender.
Male Female Unknown Gender Total Cumulative Total
Age N
% of Age 
Group 
Total
N
% of Age 
Group 
Total
N
% of Age 
Group 
Total
N
% of 
Total 
Exposure
N %
< 1 year 584 51.64 545 48.19 2 0.18 1,131 5.58 1,131 5.58
1 year 1,792 53.18 1,577 46.80 1 0.03 3,370 16.62 4,501 22.20
2 years 1,734 52.91 1,540 46.99 3 0.09 3,277 16.16 7,778 38.36
3 years 809 54.66 671 45.34 0 0.00 1,480 7.30 9,258 45.66
4 years 400 56.58 307 43.42 0 0.00 707 3.49 9,965 49.14
5 years 274 62.70 163 37.30 0 0.00 437 2.16 10,402 51.30
Unknown ≤ 5 years 3 100.00 0 0.00 0 0.00 3 0.01 10,405 51.31
Child 6 - 12 years 702 59.90 469 40.02 1 0.09 1,172 5.78 11,577 57.09
Teen 13 - 19 years 645 35.19 1,186 64.70 2 0.11 1,833 9.04 13,410 66.13
Unknown child 4 50.00 3 37.50 1 12.50 8 0.04 13,418 66.17
Subtotal 6,947 51.77 6,461 48.15 10 0.07 13,418 66.17 13,418 66.17
20 - 29 years 808 45.27 977 54.73 0 0.00 1,785 8.80 15,203 74.97
30 - 39 years 612 43.37 799 56.63 0 0.00 1,411 6.96 16,614 81.93
40 - 49 years 411 38.48 657 61.52 0 0.00 1,068 5.27 17,682 87.20
50 - 59 years 387 40.95 558 59.05 0 0.00 945 4.66 18,627 91.86
60 - 69 years 316 42.93 419 56.93 1 0.14 736 3.63 19,363 95.49
70 - 79 years 175 37.88 287 62.12 0 0.00 462 2.28 19,825 97.77
80 - 89 years 80 32.13 169 67.87 0 0.00 249 1.23 20,074 98.99
≥ 90 years 24 38.71 38 61.29 0 0.00 62 0.31 20,136 99.30
Unknown adult 45 47.87 49 52.13 0 0.00 94 0.46 20,230 99.76
Subtotal 2,858 41.96 3,953 58.03 1 0.01 6,812 33.59 20,230 99.76
Total* 9,812 48.39 10,430 51.44 36 0.18 20,278 100.00 20,278 100.00
*Total includes 48 unknown age cases.
Table 3. Origin of call and site of exposure for human exposure cases.
Site Origin of Call Site of Exposure
N % N %
Residence
Own 13,773 67.92 18,315 90.32
Other 317 1.56 703 3.47
Workplace 269 1.33 438 2.16
Health care facility 4,892 24.12 77 0.38
School 52 0.26 221 1.09
Restaurant/food service 4 0.02 36 0.18
Public area 70 0.35 175 0.86
Other 889 4.38 227 1.12
Unknown 12 0.06 86 0.42
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Table 4. Route of human exposures.
Human Exposures
Route N % of All Routes % of All Cases
Ingestion 17,466 80.54 86.13
Dermal 1,663 7.67 8.20
Inhalation/nasal 1,159 5.34 5.72
Ocular 820 3.78 4.04
Bite/sting 203 0.94 1.00
Unknown 168 0.77 0.83
Parenteral 148 0.68 0.73
Other 23 0.11 0.11
Otic 22 0.10 0.11
Rectal 7 0.03 0.03
Aspiration (with ingestion) 4 0.02 0.02
Vaginal 4 0.02 0.02
Total number of routes 21,687 100.00 106.95
*Some cases may have multiple routes of exposure documented. 
Table 5. Substance categories most frequently involved in 
exposures for ages five years or less.
Substance Category All Substance %
Single 
Substance 
Exposures
%
Cosmetics/personal care 
products 1,255 11.48 1,221 12.16
Cleaning substances 
(household) 1,251 11.44 1,204 11.99
Analgesics 996 9.11 886 8.82
Antihistamines 607 5.55 543 5.41
Foreign bodies/toys/
miscellaneous 541 4.95 523 5.21
Topical preparations 534 4.88 514 5.12
Vitamins 468 4.28 417 4.15
Pesticides 429 3.92 417 4.15
Dietary supplements/herbals/
homeopathic 409 3.74 378 3.76
Gastrointestinal preparations 292 2.67 257 2.56
Plants 275 2.51 268 2.67
Antimicrobials 237 2.17 217 2.16
Electrolytes and minerals 231 2.11 205 2.04
Cold and cough preparations 222 2.03 199 1.98
Hormones and hormone 
antagonists 202 1.85 156 1.55
Table 6. Substance categories most frequently involved in 
exposures of adults (> 19 years).
Substance Category All Substance %
Single 
Substance 
Exposures
%
Analgesics 1,160 11.45 489 9.55
Sedative/hypnotics/
antipsychotics 1,127 11.12 357 6.97
Antidepressants 848 8.37 274 5.35
Cardiovascular drugs 713 7.04 231 4.51
Alcohols 482 4.76 56 1.09
Cleaning substances 
(household) 437 4.31 342 6.68
Anticonvulsants 427 4.21 123 2.40
Antihistamines 416 4.10 179 3.49
Pesticides 397 3.92 153 2.99
Hormones and hormone 
antagonists 308 3.04 153 2.99
Stimulants and street drugs 295 2.91 106 2.07
Fumes/gases/vapors 230 2.27 206 4.02
Chemicals 223 2.20 186 3.63
Cosmetics/personal care 
products 216 2.13 187 3.65
Muscle relaxants 211 2.08 76 1.48
There was a total of 395 plant exposures reported to the PCC. The 
most common plant exposure encountered was to pokeweed (Phyto-
lacca americana) (n = 45). Table 7 lists the top five most encountered 
plants.
Table 7. Top five most frequent plant exposures.
Botanical Name or Category N
Phytolacca americana (L.) (Pokeweed) 45
Cherry (Species unspecified) 18
Plants - Toxicodendrol 16
Philodendron (Species unspecified) 13
Spathiphyllum species (Botanic name) 10
Unknown plant 28
Unintentional exposures were the most common reason for expo-
sures (78.6%, n = 15,947) while intentional exposures accounted for 
18.8% (n = 3,818) of exposures. Compared to 2016, there was a 12.5% 
increase in the number of intentional exposures (n = 441). Table 8 
lists reasons for human exposures. Most unintentional exposures, 
65.0% (n = 10,361), occurred in the less than five years old age group. 
Up to 12 years of age, 98.5% (n = 11,577) of ingestions were uninten-
tional. However, in the 13 - 19 age group, intentional exposure was 
most common (67%, n = 1,229). In total, suspected suicide attempts 
accounted for 14.3% (n = 2,906) of human encounters. This was an 
increase of 17% (n = 491) compared to 2016 data. When a therapeu-
tic error was the reason for exposure, a double dose was the most 
common scenario, 29.4% (n = 727).
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Reason N % Human Exposures
Unintentional
General 10,847 53.5
Therapeutic error 2,395 11.8
Misuse 1,371 6.8
Environmental 596 2.9
Occupational 345 1.7
Bite/sting 206 1.0
Food poisoning 165 0.8
Unknown 22 0.1
Subtotal 15,947 78.6
Intentional
Suspected suicide 2,906 14.3
Misuse 486 2.4
Abuse 335 1.7
Unknown 91 0.4
Subtotal 3,818 18.8
Adverse reaction
Drug 241 1.2
Other 65 0.3
Food 37 0.2
Subtotal 343 1.7
Unknown
Unknown reason 89 0.4
Subtotal 89 0.4
Other
Malicious 56 0.3
Contamination/
tampering
15 0.1
Withdrawal 10 0.0
Subtotal 81 0.4
Total 20,278 100.0
Most encounters (69.4%, n = 14,073) were managed in a non-health 
care facility (i.e., a residence). Of the 5,982 encounters managed at a 
health care facility, 47.7% (n = 2,851) were admitted.  Table 9 lists the 
management site of all human encounters.
Among human exposures, 14,940 involved exposures to pharma-
ceutical agents while 9,896 involved exposure to non-pharmaceuticals. 
Because an encounter could include numerous pharmaceutical and 
non-pharmaceutical agents, this total is greater than the total number 
of encounters. However, 87.3% (n = 17,700) of all human exposures 
were exposed to only a single substance. Among these single sub-
stance exposures, the reason for exposure was intentional in 22.2% 
(n = 1,980) of pharmaceutical-only cases compared to 3.6% (n = 319) 
of non-pharmaceutical single substance exposures.
When medical outcomes were analyzed, 28.3% (n = 5,741) of 
human exposures had no effect, 18.2% (n = 3,693) had minor effect, 
8.5% (n = 1,739) had moderate effect, and 2.1% (n = 431) major effects. 
Moderate and major effects were more common in those over 20 
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years of age and in those with intentional encounters. More serious 
outcomes were related to single-substance pharmaceutical exposures, 
accounting for 25% (n = 4) of the fatalities. Table 10 lists all medical 
outcomes by age and Table 11 lists outcomes by reason for exposure.
Use of decontamination and specific therapies, including anti-
dotal therapy, is detailed in Tables 12a and 12b. Sixteen deaths were 
reported to the PCC in 2017 (Table 13). Fourteen deaths involved 
adult patients. Twelve deaths involved intentional exposures. 
Table 14 compares key statistics from 2015, 2016, and 2017. While 
total number of exposures declined in 2017 compared to 2016, calls 
from health care facilities, moderate or major outcomes, and deaths 
continued to increase. 
Table 9. Management site of human exposures.
Site of Management N %
Healthcare facility
Treated/evaluated and released 3,131 15.4
Admitted to critical care unit 1,449 7.2
Admitted to noncritical care unit 719 3.6
Admitted to psychiatric facility 481 2.4
Patient lost to follow-up/left AMA 202 1.0
Healthcare Facility Subtotal 5,982 29.5
Non-healthcare facility 14,073 69.4
Other 28 0.1
Refused referral 175 0.9
Unknown 20 0.1
Total 20,278 100.0
DISCUSSION
The University of Kansas Health System Poison Control Center 
has been in operation for 36 years and receives over 21,000 calls per 
year. The PCC is an integral part of the emergency medical response, 
public health, and health care facilities in Kansas.  Childhood poison-
ings, both unintentional and intentional, are a major focus, with calls 
for patients under 19 years of age accounting for approximately two-
thirds of all exposures. 
The PCC statistics reflect the trends seen nationally.1 In 2017, 
2,607,413 encounters were logged by poison control centers nation-
wide, including 2,115,186 human exposures. Total encounters showed 
a 3.79% decline from 2016 but health care facility human exposure 
cases increased by 3.06%. More serious outcomes (moderate, major, 
or death) have increased since 2000. Nationwide, the five substance 
classes most frequently involved in adult exposures were analgesics, 
sedative/hypnotics/antipsychotics, antidepressants, cardiovascular 
drugs, and cleaning substances (household), while the top five most 
common exposures in children age five years or less were cosmetics/
personal care products, household cleaning substances, analgesics, 
foreign bodies/toys/miscellaneous, and topical preparations. There 
were 2,682 exposure related fatalities reported nationwide in 2017, 
an increase of 1,190 deaths from 2016. 2
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Table 10. Medical outcome of human exposure cases by patient age. 
≤ 5 Years 6 - 12 Years 13 - 19 Years ≥ 20 Years Unknown Child
Unknown 
Adult
Unknown 
Age Total
Outcome N % N % N % N % N % N % N % N %
No effect 3,843 36.93 280 23.89 477 26.02 1,112 16.55 1 12.50 6 6.38 22 45.8 5,741 28.31
Minor 
effect
1,137 10.93 232 19.80 562 30.66 1,733 25.80 1 12.50 26 27.66 2 4.2 3,693 18.21
Moderate 
effect
122 1.17 37 3.16 371 20.24 1,206 17.95 0 0.00 3 3.19 0 0.0 1,739 8.58
Major 
effect
15 0.14 8 0.68 51 2.78 357 5.31 0 0.00 0 0.00 0 0.0 431 2.13
Death 0 0.00 1 0.09 1 0.05 14 0.21 0 0.00 0 0.00 0 0.0 16 0.08
No 
follow-up, 
nontoxic
381 3.66 34 2.90 13 0.71 30 0.45 0 0.00 3 3.19 0 0.0 461 2.27
No 
follow-up, 
minimal 
toxicity
4,566 43.88 511 43.60 263 14.35 1,709 25.44 4 50.00 38 40.43 8 16.7 7,099 35.01
No 
follow-up, 
potentially 
toxic
240 2.31 41 3.50 69 3.76 267 3.97 2 25.00 15 15.96 14 29.2 648 3.20
Unrelated 
effect
101 0.97 28 2.39 26 1.42 290 4.32 0 0.00 3 3.19 2 4.2 450 2.22
Death, 
indirect 
report
0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.0 0 0.00
Total 10,405 100.00 1,172 100.00 1,833 100.00 6,718 100.00 8 100.00 94 100.00 48 100.00 20,278 100.00
Table 11. Medical outcome by reason for exposure in human exposures. 
Unintentional Intentional Other Adverse Reaction Unknown Total
Outcome N % N % N % N % N % N %
Death 1 0.01 13 0.34 0 0.00 0 0.00 2 2.25 16 0.08
Death, indirect 
report
0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Major effect 67 0.42 339 8.88 3 3.70 7 2.04 15 16.85 431 2.13
Minor effect 2,455 15.39 1,107 28.99 22 27.16 100 29.15 9 10.11 3,693 18.21
Moderate 
effect
537 3.37 1,128 29.54 9 11.11 45 13.12 20 22.47 1,739 8.58
No effect 4,864 30.50 842 22.05 13 16.05 15 4.37 7 7.87 5,741 28.31
No follow-up, 
nontoxic
443 2.78 16 0.42 1 1.23 1 0.29 0 0.00 461 2.27
No follow-up, 
minimal 
toxicity
6,810 42.70 172 4.50 14 17.28 90 26.24 13 14.61 7,099 35.01
No follow-up, 
potentially 
toxic
445 2.79 162 4.24 10 12.35 18 5.25 13 14.61 648 3.20
Unrelated 
effect
325 2.04 39 1.02 9 11.11 67 19.53 10 11.24 450 2.22
Total 15,947 100.00 3,818 100.00 81 100.00 343 100.00 89 100.00 20,278 100.00
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Table 12a. Decontamination provided in human exposures by age.
Decontamination ≤ 5 Years 6 - 12 Years 13 - 19 Years ≥ 20 Years Unknown Child
Unknown 
Adult
Unknown 
Age Total
Cathartic 1 2 18 16 0 0 0 37
Charcoal, multiple doses 2 0 9 8 0 0 0 19
Charcoal, single dose 55 11 153 192 0 0 0 411
Dilute/irrigate/wash 7,870 754 444 2,559 2 38 3 11,670
Food/snack 1,589 140 67 355 1 4 0 2,156
Fresh air 105 41 60 442 1 18 22 689
Lavage 0 0 1 5 0 0 0 6
Other emetic 61 6 13 32 0 0 0 112
Whole bowel irrigation 1 1 3 10 0 0 0 15
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Table 12b. Therapy provided in human exposures by age.
Therapy ≤ 5 Years 6 - 12 Years 13 - 19 Years ≥ 20 Years Unknown Child Unknown Adult Unknown Age Total
Alkalinization 2 1 48 140 0 0 0 191
Antiarrhythmic 1 0 1 9 0 0 0 11
Antibiotics 23 8 14 159 0 0 0 204
Anticonvulsants 0 1 1 5 0 0 0 7
Antiemetics 22 5 115 231 0 0 0 373
Antihistamines 23 14 11 76 0 0 0 125
Antihypertensives 1 1 2 20 0 0 0 24
Antivenin/antitoxin 0 1 2 6 0 0 0 9
Antivenin (fab fragment) 2 3 1 18 0 0 0 24
Atropine 0 1 1 15 0 0 0 17
Benzodiazepines 18 5 80 296 0 0 0 399
Bronchodilators 7 4 9 63 0 0 0 83
Calcium 156 8 4 26 0 0 0 194
Cardioversion 0 0 0 2 0 0 0 2
CPR 0 0 0 7 0 0 0 7
Deferoxamine 0 0 1 1 0 0 0 2
Fab fragments 1 0 4 4 0 0 0 9
Fluids, IV 75 24 558 1,502 0 0 0 2,159
Flumazenil 0 0 7 43 0 0 0 50
Folate 0 0 0 2 0 0 0 2
Fomepizole 0 1 0 17 0 0 0 18
Glucagon 0 0 1 25 0 0 0 26
Glucose, > 5% 0 0 7 45 0 0 0 52
Hemodialysis 0 0 0 22 0 0 0 22
Hemoperfusion 0 0 0 1 0 0 0 1
Hydroxocobalamin 0 0 0 4 0 0 0 4
Hyperbaric oxygen 0 2 1 6 0 0 0 9
Insulin 0 0 1 25 0 0 0 26
Intubation 8 2 32 199 0 0 0 241
Methylene blue 0 0 0 3 0 0 0 3
NAC, IV 0 2 85 157 0 0 0 244
NAC, PO 0 0 25 17 0 0 0 42
Naloxone 10 1 17 153 0 0 0 181
Neuromuscular blocker 0 0 1 14 0 0 0 15
Octreotide 0 0 0 5 0 0 0 5
Oxygen 23 11 64 421 0 0 0 519
Physostigmine 0 0 2 8 0 0 0 10
Phytonadione 0 0 2 7 0 0 0 9
Sedation (other) 9 3 31 173 0 0 0 216
Sodium thiosulfate 0 0 0 1 0 0 0 1
Steroids 13 3 4 67 0 1 0 88
Succimer 0 0 0 4 0 0 0 4
Vasopressors 1 1 5 79 0 0 0 86
Ventilator 8 2 30 195 0 0 0 235
Other 66 25 96 444 0 2 0 633
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Table 13. Details on deaths and exposure related fatalities. 
Non-Pharmaceutical Exposures Age, Gender Substances Substance Rank Cause Rank Chronicity Route Reason***
Cleaning substances (household) 58 years, Male Drain Cleaner 1 1 Acute Ingestion Int. - suicide
Fumes/gases/vapors 64 years, Male Carbon Monoxide 1 1 Acute Inhalation Unint. - Env.
Heavy metals 59 years, Male Arsenic 1 1 Acute Ingestion  Int. - suicide
Benzene 2 2
Toluene 3 3
Pharmaceutical Exposures
Analgesics 32 years, Female Acetaminophen 1 1 Acute Ingestion  Int. - suicide
56 years, Male Acetaminophen/Oxycodone 1 1 Acute Ingestion  Int. - suicide
Alprazolam* 2 2
Drug, unknown 3 3
76 years, Female Acetaminophen 1 1 Acute Ingestion  Int. - suicide
76 years, Male Salicylate 1 1 Acute Ingestion  Int. - suicide
Cardiovascular drugs 9 years, Female Clonidine 1 1 Acute Ingestion  Unknown
Cationic detergent 2 2
Cyproheptadine 3 3
Methylphenidate 4 4
Alpha-adrenergic blocker 5 5
Desmopressin 6 6
26 years, Male Nebivolol 1 1 Acute Ingestion  Int. - suicide
Hydrochlorothiazide/
Losartan 2 2
57 years, Female Diltiazem (extended release) 1 1 Acute Ingestion  Int. - suicide
Sotalol 2 2
Apixaban 3 3
Losartan 4 4
Cholecalciferol 5 5
Folic Acid 6 6
Ethanol 7 7
Dietary supplements/herbals/homeopathic 19 years, Male Piper Methysticum 1 1 Acute Ingestion  Int.- abuse
Sertraline 2 2
Hormones and hormone antagonists 31 years, Female Metformin 1 1 Acute on Chronic Ingestion Int. - suicide
Ibuprofen** 2 2
Miscellaneous drugs 50 years, Female Ropinirole 1 1 Acute on Chronic Ingestion Int. - suicide
Clopidogrel 2 2
Alprazolam* 3 3
Ethanol 4 4
Sedative/hypnotics/antipsychotics 44 years, Male Ziprasidone 1 1 Acute on Chronic Ingestion Int. - suicide
Valproic Acid 
(extended release) 2 2
Acetaminophen/
hydrocodone** 3 3
Stimulants and street drugs 26 years, Male Methamphetamine 1 1 Acute Unknown Unknown
Amphetamine 2 2
28 years, Male Methamphetamine 1 1 Acute Ingestion
Int. - 
unknown 
reason 
*Also sedative/hypnotics/antipsychotics
**Also analgesic
***int. - intentional; unint. - unintentional; env. - environmental 78
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Table 14. 2015 to 2017 comparison of select statistics.
2015 2016 2017
Total cases 20,109 21,965 21,431
Calls from HCF 4,267 4,514 4,892
Moderate or major 
outcomes 1,688 1,971 2,170
Deaths 13 15 16
The ongoing importance of the PCC is reflected in increasing 
trends in rates of poisonings and overdoses that have reached epidem-
ic proportions in some cases. The PCC saw an increase in number of 
calls from health care facilities, cases with moderate or major medical 
outcomes, and deaths in 2017 compared to 2016. This is consistent 
with literature that notes in the United States a 9.6% increase in drug 
overdose deaths in 2017 compared to 2016.3 A vast majority of these 
deaths are related to opioids and one study projects an increase of 
opioid related deaths from 42,200 in 2016 to over 80,000 per year 
by 2025.4 Adolescent intentional overdose also impacts the increase 
in morbidity. Several studies have documented increasing numbers of 
adolescent overdose with subsequent increase in morbidity.5-7
Reporting exposures to the PCC is voluntary and the PCC is not 
contacted for all poisonings in the state of Kansas. Furthermore, in 
most cases, there is no objective confirmation of exposure. These limi-
tations should be noted when interpreting PCC data.
CONCLUSION
The results of the 2017 University of Kansas Health System Poison 
Control annual report demonstrated that the center continues to 
receive calls from the entire state of Kansas totaling over 20,000 
human exposures per year. While pediatric exposures remain the 
most common, there is an increasing number of calls from health 
care facilities and for cases with serious outcomes. The experience 
of the PCC reflects the national trends of increasing morbidity and 
mortality associated with overdoses and other exposures. This report 
demonstrated the continued value of the PCC to both the public and 
to health care providers in the state of Kansas.
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